UK Health Secretary Matt Hancock claimed that a coronavirus vaccine is "most likely" to be ready in the first few months of 2021, if it gets approved.
In a statement on Monday, Hancock said it was "looking up" that the vaccine being developed by experts at the University of Oxford and pharmaceutical giant AstraZeneca would be granted approval for use soon after trials in several countries, including the UK, the US and Brazil, Xinhua news agency reported.
His statement came at a time when countries, such as the UK, China, Russia and the US, are engaged in a race against time to develop a vaccine for the novel coronavirus.
The manufacturing of doses was already starting, Hancock said, so that it could be "rolled out" across the country when given the all-clear.
A vaccine would be a game-changer in combating the ovid-19 pandemic, giving vital protection particularly to the elderly and other vulnerable people, though it could take many months to roll out across the population, said the newspaper.
The UK may also be facing difficult months this autumn and winter seasons because Covid-19 cases and hospitalizations are expected to rise, though doctors have significantly improved care, raising hopes that the death rate will be far lower.
As of Tuesday, the UK has reported a total of 352,451 coronavirus cases, with 41,643 deaths.
--IANS
ksk/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)